Market Place

Market Place

Market Place

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search
All
API
FDF
Price
Services
Excipients
Enquiries

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Price
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    Scorr-Insert
    X

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    A collaboration with SCORR Marketing

    Loading...

    All Data

    Filters Filter refresh
    ×
    FILTER DATA :
    News Type filter
      Company filter
        Product Type filter
          Deal Size filter
            Upfront Payment filter
              refresh

              Product Type Full Screen

              Companies Full Screen

              Vibalogics

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              GERMANY Germany

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              BIO International Convention

              Participation Not Confirmed

              Update your events

              Vibalogics Announces Collaboration to Provide Additional Clinical Trial Material for COVID-19 Vaccine Candidate

              Contact the Supplier

              Lead Product(s): COVID-19 vaccine

              Therapeutic Area: Infections and Infectious Diseases

              Highest Development Status: Undisclosed Product Type: Vaccine

              Partner/Sponsor/Collaborator: Johnson & Johnson

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Collaboration May 19, 2020

              Details:

              Under the contract, Vibalogics will produce multiple batches of the vaccine candidate at its facility in Cuxhaven, Germany, expected to yield thousands of vaccine doses.

              Exyte

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              GERMANY Germany

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              BIO International Convention

              Participation Not Confirmed

              Update your events

              Exyte and Univercells Combine Forces for Rapid Deployment of Vaccine

              Contact the Supplier

              Lead Product(s): COVID-19 vaccine

              Therapeutic Area: Infections and Infectious Diseases

              Highest Development Status: Undisclosed Product Type: Vaccine

              Partner/Sponsor/Collaborator: Univercells

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership May 14, 2020

              Details:

              Through this partnership, an integrated plant design combines Exyte’s prefabricated modular construction system, ExyCell, with Univercells Technologies’ NevoLine biomanufacturing platform featuring the scale-X fixed-bed bioreactor at its core.

              OntoChem

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              GERMANY Germany

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              BIO International Convention

              Participation Not Confirmed

              Update your events

              Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics

              Contact the Supplier

              Lead Product(s): Antiviral drugs

              Therapeutic Area: Infections and Infectious Diseases

              Highest Development Status: Undisclosed Product Type: Small molecule

              Partner/Sponsor/Collaborator: Anixa Biosciences

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Collaboration April 20, 2020

              Details:

              The strategic collaboration focuses on discovery and development of anti-viral drug candidates for COVID-19.

              Bayer HealthCare

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              GERMANY Germany

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              BIO International Convention

              Participation Not Confirmed

              Update your events

              Bayer Partners with U.S. Government on Major Product Donation to Fight Coronavirus

              Contact the Supplier

              Lead Product(s): Chloroquine Phosphate

              Therapeutic Area: Infections and Infectious Diseases

              Highest Development Status: Undisclosed Product Type: Small molecule

              Partner/Sponsor/Collaborator: U.S. Government

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership March 19, 2020

              Details:

              Bayer is working with appropriate agencies on an Emergency Use Authorization for the drug’s use in the U.S.

              PharmaCompass__DigitalAd